1. Entezari Z, Injinari N, Vakili M, Namiranian N. Identification of Factors Related to Sexual Dysfunction in Type 2 Diabetic Women. Iranian journal of diabetes and obesity. 2023; 15(2): 66-72. [
DOI:10.18502/ijdo.v15i2.12963]
2. Mehrabbeik A, Azizi R, Rahmanian M, Namiranian N, Shukohifar M, Asi M. Design and Psychometrics of Diabetes Knowledge Questionnaire. Journal of Medical Education. 2022;21(1): e130597. [
DOI:10.5812/jme-130597]
3. Hafez SM, Allam FA, Elbassuoni E. Sex differences impact the pancreatic response to chronic immobilization stress in rats. Cell Stress and Chaperones. 2021;26(1):199-215. [
DOI:10.1007/s12192-020-01169-y]
4. Rosen ED, Kaestner KH, Natarajan R, Patti ME, Sallari R, Sander M, et al. Epigenetics and epigenomics: implications for diabetes and obesity. Diabetes. 2018;67(10):1923-31. [
DOI:10.2337/db18-0537]
5. Ciarambino T, Crispino P, Leto G, Mastrolorenzo E, Para O, Giordano M. Influence of gender in diabetes mellitus and its complication. International journal of molecular sciences. 2022;23(16):8850. [
DOI:10.3390/ijms23168850]
6. Kautzky-Willer A, Harreiter J. Sex and gender differences in therapy of type 2 diabetes. Diabetes Research and Clinical Practice. 2017;131:230-41. [
DOI:10.1016/j.diabres.2017.07.012]
7. Wright AK, Kontopantelis E, Emsley R, Buchan I, Mamas MA, Sattar N, et al. Cardiovascular risk and risk factor management in type 2 diabetes mellitus: a population-based cohort study assessing sex disparities. Circulation. 2019;139(24):2742-53. [
DOI:10.1161/CIRCULATIONAHA.118.039100]
8. Hendriks SH, Blanker MH, Roelofsen Y, van Hateren KJ, Groenier KH, Bilo HJ, et al. Gender differences in the evaluation of care for patients with type 2 diabetes: a cross-sectional study (ZODIAC-52). BMC Health Services Research. 2018;18:1-9. [
DOI:10.1186/s12913-018-3086-x]
9. Azimi-Nezhad M, Ghayour-Mobarhan MP, Parizadeh MR, Safarian M, Esmaeili H, Parizadeh SM, et al. Prevalence of type 2 diabetes mellitus in Iran and its relationship with gender, urbanisation, education, marital status and occupation. Singapore medical journal. 2008;49(7):571.
10. Shahwan MJ, Jairoun AA, Farajallah A, Shanabli S. Prevalence of dyslipidemia and factors affecting lipid profile in patients with type 2 diabetes. Diabetes & Metabolic Syndrome: Clinical Research & Reviews. 2019;13(4):2387-92. [
DOI:10.1016/j.dsx.2019.06.009]
11. Wright AK, Kontopantelis E, Emsley R, Buchan I, Mamas MA, Sattar N, et al. Cardiovascular risk and risk factor management in type 2 diabetes mellitus: a population-based cohort study assessing sex disparities. Circulation. 2019;139(24):2742-53. [
DOI:10.1161/CIRCULATIONAHA.118.039100]
12. Peters SA, Woodward M. Sex differences in the burden and complications of diabetes. Current diabetes reports. 2018;18(6): 33. [
DOI:10.1007/s11892-018-1005-5]
13. Holven KB, van Lennep JR. Sex differences in lipids: a life course approach. Atherosclerosis.2023;384:117270. [
DOI:10.1016/j.atherosclerosis.2023.117270]
14. Connelly PJ, Azizi Z, Alipour P, Delles C, Pilote L, Raparelli V. The importance of gender to understand sex differences in cardiovascular disease. Canadian Journal of Cardiology. 2021 ;37(5):699-710. [
DOI:10.1016/j.cjca.2021.02.005]
15. Hussain A, Ali I, Kaleem WA, Yasmeen F. Correlation between body mass index and lipid profile in patients with type 2 diabetes attending a tertiary care hospital in Peshawar. Pakistan journal of medical sciences.2019;35(3):591-7. [
DOI:10.12669/pjms.35.3.7]
16. Găman MA, Cozma MA, Dobrică EC, Bacalbașa N, Bratu OG, Diaconu CC. Dyslipidemia: a trigger for coronary heart disease in Romanian patients with diabetes. Metabolites. 2020;10(5):195. [
DOI:10.3390/metabo10050195]
17. Angoulvant D, Ducluzeau PH, Renoult-Pierre P, Fauchier G, Herbert J, Semaan C, et al. Impact of gender on relative rates of cardiovascular events in patients with diabetes. Diabetes & metabolism. 2021;47(5):101226. [
DOI:10.1016/j.diabet.2021.101226]
18. Cherchi S, Gigante A, Spanu MA, Contini P, Meloni G, Fois MA, et al. Sex-gender differences in diabetic retinopathy. Diabetology. 2020;1(1):1-10. [
DOI:10.3390/diabetology1010001]
19. Lundeen EA, Burke-Conte Z, Rein DB, Wittenborn JS, Saaddine J, Lee AY, Flaxman AD. Prevalence of diabetic retinopathy in the US in 2021. JAMA ophthalmology. 2023;141(8):747-54. [
DOI:10.1001/jamaophthalmol.2023.2289]
20. Li M, Wang Y, Liu Z, Tang X, Mu P, Tan Y, et al. Females With Type 2 Diabetes Mellitus Are Prone to Diabetic Retinopathy: A Twelve‐Province Cross‐Sectional Study in China. Journal of diabetes research. 2020;2020(1):5814296. [
DOI:10.1155/2020/5814296]
21. Hashemi H, Rezvan F, Pakzad R, Ansaripour A, Heydarian S, Yekta A, et al. Global and Regional Prevalence of Diabetic Retinopathy; A Comprehensive Systematic Review and Meta-analysis. Seminars in Ophthalmology. 2022;37(3):291-306. [
DOI:10.1080/08820538.2021.1962920]
22. Sultan S, Fawwad A, Siyal NA, Butt A, Khokar AR, Basit A. Frequency and risk factors of diabetic retinopathy in patients with type 2 diabetes presenting at a tertiary care hospital. International Journal of Diabetes in Developing Countries. 2020;40:87-92. [
DOI:10.1007/s13410-019-00756-9]
23. Giandalia A, Giuffrida AE, Gembillo G, Cucinotta D, Squadrito G, Santoro D, et al. Gender differences in diabetic kidney disease: focus on hormonal, genetic and clinical factors. International journal of molecular sciences. 2021;22(11):5808. [
DOI:10.3390/ijms22115808]
24. Thomas B. The Global Burden of Diabetic Kidney Disease: Time Trends and Gender Gaps. Current Diabetes Reports. 2019;19(4):18. [
DOI:10.1007/s11892-019-1133-6]